In the final segment, Nurse Sandy presents the case of a patient with resectable non-small cell lung cancer and discusses why timely biomarker results matter before surgery, the evidence for adjuvant targeted therapy in EGFR, ALK, and RET positive disease, and how she educates patients starting a RET inhibitor.

So we think so much about biomarkers in patients with metastatic non-small cell lung cancer, but this has now moved to the early stage curative intense space.

So this is really exciting.

And I drew three lines because I like Dr. Alder's stars in the little pie piece there.

So we have three approvals here in the respectable non-small cell lung cancer space.

So this is my case presentation.

This is a 77 year old Caucasian female who presents for evaluation after persistent nagging cough led her to get a chest x-ray and that CT of the chest noted a 4.5 centimeter right upper lung mass.

smaller